Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 71 to 80 of 148 resources
-
New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
This article provides analysis of the estimated impact of new treatment for hepatitis C on both the prevention of transmission of the virus, and on preventing hepatitis C-related liver disease.
It concludes that focusing treatment solely on people with cirrhosis is not a tenable long-term strategy if continued reductions in new cases of end stage liver disease and hepatocellular carcinoma, as well as reductions in transmission are to be achieved. It also finds that treatment of other groups will need to follow quickly if these reductions are to be achieved.England Apr 2016 Reports & Research PDF -
Hepatitis C ODNs and Clinical Leads
Operational Delivery Networks (ODNs) are the new structures through which hepatitis C treatment in England is being delivered. The Network involves regional centres which manage treatment decisions and prescribing, and which have a dispersed treatment model which aims to support partnership working and access for local patients.
This graphic details each ODN across England, along with the named ODN Clinical Lead for each.England Apr 2016 Other, Strategy & Planning PDF -
Guidance: Hepatitis C prevention, diagnosis and treatment in prisons in England
This document, published by The Hepatitis C Trust after convening an expert group of prison healthcare commissioners and practitioners, provides commissioners and prison healthcare teams with practical guidance regarding the implementation of opt-out BBV testing and related hepatitis C care pathways, which can be adapted and used by any prison that needs to develop, revise or update their services.UK, England Mar 2016 Reports & Research, Tools & Templates, Strategy & Planning PDF -
The blood borne virus opt-out testing policy for prisons in England: An analysis of need towards full implementation
In recognition of the exceptionally high prevalence of blood borne viruses (BBVs), in particular hepatitis C, amongst people in prisons and previously very low rates of testing, in October 2013 Public Health England (PHE), NHS England and the National Offender Management Service (NOMS) agreed to introduce opt-out testing for hepatitis B, hepatitis C and HIV across the prison estate by 2016/17.UK, England Mar 2016 Reports & Research, Strategy & Planning PDF -
HCV Action good practice case study: Peer to Peer Hepatitis C Mentoring in Hampshire
A hepatitis C peer to peer (P2P) mentoring project established in 2012, in partnership with The Hepatitis C Trust, in order to engage with and support people who have, or may be at risk from, hepatitis C. As an extension of the project, in 2014 a series of testing events were held in order to both raise awareness of hepatitis C among people at risk, and also to increase the numbers of people tested, with mentors playing a key role in ensuring that those being engaged with were fully supported throughout.UK, England, South East Dec 2015 Case study PDF -
HCV Action & PHE hepatitis C roadshow in Brighton: Presentations
On 24th November 2015, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Brighton. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C, with a particular focus on how hepatitis C can be tackled alongside HIV and other BBVs.UK, England, South East Dec 2015 Other PDF -
Shooting Up: Infections among people who inject drugs in the UK 2014 - An update, November 2015
This annual national report describes trends in the extent of infections and associated risks and behaviours among people who inject drugs in the UK to the end of 2014. Among its findings are that:
- Two in five of those people in the UK who inject psychoactive drugs are living with hepatitis C, with around half of these infections remaining undiagnosed.
- Changing patterns of psychoactive drug injection are increasing the risk of infection.UK, England, Northern Ireland, Scotland, Wales Nov 2015 Reports & Research PDF -
HCV Action good practice case study: Going Viral project
This case-study looks at 'Going Viral', a week-long project ran across 9 hospitals which involved everyone in accident and emergency departments who was receiving a blood test also being offered a blood test for hepatitis C, hepatitis B and HIV - with the same blood sample being used.UK, England, Greater London Nov 2015 Case study PDF -
Community case-finding strategies for viral hepatitis in UK migrant populations: the South East Coast England experience
This poster details the experiences of Frimley Park Hospital NHS Foundation Trust in their efforts to offer community-based testing to the South Asian and Nepali community in the population served by the hospital. It highlights the successes that can be achieved through engaging with religious leaders; ensuring peer mentor support, and encouraging word-of-mouth promotion through motivated community figures.UK, England, South East Oct 2015 Other, Reports & Research PDF -
HCV Action and PHE hepatitis C roadshow in Birmingham: Presentations
On 23rd October HCV Action and Public Health England staged the third of their hepatitis C good practice roadshows in Birmingham, with the aim of instigating and assisting local action to tackle hepatitis C.UK, England, East Midlands, West Midlands Oct 2015 Other PDF